Myelodysplastic Syndromes Websites
Apogenix ǀ Immuno-oncology therapeutics for the treatment of cancer an
Apogenix develops innovative protein therapeutics for the treatment of cancer and other malignant diseases. Our lead drug candidate APG101 has demonstrated a statistically significant efficacy in a controlled phase II trial in recurrent glioblastoma.
3,446,235
$
480.00
Cure for Cancers - Information regarding natural ways to cure cancers
Free information on cure for cancers, natural way to recover without taking drugs or doing surgery
Not Applicable
$
8.95
Jonathan Wood & Associates - Medical Communications
Jonathan Wood & Associates, a medical communications company specializing in hematology and oncology.
Not Applicable
$
8.95
High Risk Patient Groups for PNH | PNH | Paroxysmal Nocturnal Hemoglob
To identify Paroxysmal Nocturnal Hemoglobinuria (PNH) earlier, know which patients are at risk.
Not Applicable
$
8.95
